Decline is not inevitable.
A daily, evidence-graded view of everything moving in kidney research : the drugs that slow decline, the science of regeneration, and the mind-body work.
Older, cheaper kidney drugs work just as well as the new expensive ones.
Today's news focuses on practical options for managing kidney disease. The most important finding is that you do not need the newest, most expensive drugs to get good protection. Older, cheaper medications appear to work just as well. Other studies looked at supplements like melatonin and turmeric, with mixed or preliminary results.
Dose-Specific Network Meta-Analysis of Mineralocorticoid Receptor Antagonists in CKD.
This large review compared different doses of kidney-protecting drugs. It found that cheaper, older drugs work just as well as the new, expensive finerenone. This is strong evidence from many large trials.
Nanocurcumin supplementation modulates inflammatory markers: a systematic review of randomized clinical trials.
This large review analyzed 32 trials on nanocurcumin, a special form of turmeric. It looked at how this supplement affects body inflammation markers. The review found that nanocurcumin can lower certain signs of inflammation. This is a summary of many studies, which makes the finding stronger.
Pharmacological Interventions for Osteoporosis in Kidney Transplant Recipients: A Systematic Review and Meta-analysis.
This review combined data from several trials on bone drugs for kidney transplant patients. It looked at how these drugs affect bone density and fracture risk. The analysis helps doctors choose the best bone treatments after a transplant. It is a high-level summary of existing evidence.
Comparison of the Effectiveness and Safety of Allopurinol and Febuxostat Use in CKD Patients with Hyperuricemia: A Systematic Review
This review looked at many studies to compare two drugs used to lower uric acid. It focused on people with kidney disease. The review found that both drugs are generally safe for these patients. This helps doctors choose the right treatment to protect the kidneys and heart.
Nurse-involved advance care planning for adults receiving maintenance dialysis: a systematic review of decision-quality and psychosocial outcomes
This review looked at many studies on how nurses help dialysis patients plan for end-of-life care. It found that this support improves how well patients make decisions. It also helps with their emotional well-being.
Pregnancy and perinatal outcomes following exposure to GLP-1 and dual GLP-1/GIP receptor agonists: a time-window-stratified systematic review and meta-analysis.
This review combined data from many studies to check the safety of GLP-1 drugs during pregnancy. It looked at how these drugs affect the mother and baby. This is a meta-analysis, which is the strongest type of evidence.
Adjunctive fucoidan, fucoxanthin, and l-carnitine mitigate albuminuria and preserve eGFR over a 12-week treatment period in diabetic kidney disease: A translational study and proof-of-concept randomized clinical trial.
A small trial of 63 people with diabetic kidney disease tested a marine supplement. Over 12 weeks, the supplement helped keep kidney function stable. It also reduced protein in the urine. This is a small test, so more proof is needed.
Effect of Melatonin on 24-Hour Urinary Protein Excretion and Sleep Quality in Patients With Stage 3-4 Chronic Kidney Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
This study tested melatonin in adults with stage 3-4 kidney disease. It ran for 12 weeks and compared the supplement to a placebo. The goal was to see if melatonin lowers protein in the urine. Protein in the urine is a sign of kidney damage. The text does not list the total number of people in the trial. It also does not state the final results of the test.
Comparison of Contrast Bath Therapy and Ankle Pump Exercises on Edema Reduction in Kidney Failure Patients at Sembiring Deli Tua General Hospital in 2026
This small study compared two ways to reduce swelling in 34 people with kidney failure. One group used contrast baths, and the other did ankle exercises. It was a short-term test, so it shows a link but not long-term proof.
Effects of a Nurse-Led Multicomponent Exercise Intervention for Haemodialysis Patients With Possible or Confirmed Sarcopenia: A Cluster Randomised Trial.
This trial tested a 12-week exercise program for 56 dialysis patients with muscle loss. The program was led by nurses. It aimed to improve muscle strength and quality of life. The study is small, but it shows exercise can help these patients.
Subcutaneous Defibrillator for Primary Prevention in Chronic Kidney Disease Stage 3-5: The Single-Arm STEADIED Study.
This study tested a heart device in 39 people with kidney disease. The device is meant to stop sudden heart attacks. The study ended early, so it is small. It shows the device works in this group, but more people are needed to be sure.
Is Peri-Renal Fat Thickness Associated With Progression to Chronic Kidney Disease After Radical Nephrectomy?
This study looked at people who had a kidney removed for cancer. It checked if the amount of fat around the other kidney linked to kidney decline. The results show a link, but not proof of cause. This is an observational study of a specific patient group.
Global, regional, and national burden and trends in chronic kidney disease attributable to metabolic risk, 1990-2021: based on global burden of disease data, 2021.
This study looked at global health data from 1990 to 2021. It found that kidney disease from metabolic risks has risen sharply. It shows a trend in the population, but it does not prove what causes the rise in any single person.
Predicting cardiovascular disease in peritoneal dialysis patients using glycated proteomics and machine learning: A prospective multicentre study.
This study used blood tests to build a tool for predicting heart disease in dialysis patients. It shows a link between these markers and heart risk, but it is not proof of cause.
Sex Hormones and CKD Progression in Type 2 Diabetes: Look AHEAD Sex Hormone Study
This study found that sex hormones may explain why men with diabetes lose kidney function faster than women. It looked at hormone levels and how quickly kidney disease progressed. This is an observational study, so it shows a link, not proof of cause. The findings help us understand the biological reasons behind these differences.
Associations of Coexisting Metabolic Dysfunction‐Associated Steatotic Liver Disease and Sarcopenia‐Related Abnormalities With Adverse Clinical Outcomes Across Obesity States
A large study of 438,748 people in the UK found a link between low muscle strength and kidney disease. The risk was higher when people also had fatty liver disease. This study shows a link, not proof of cause. It suggests that muscle health matters for kidney health.
Alkaline Phosphatase and Cumulative Vascular Access Burden in Maintenance Hemodialysis: An Exploratory Clinical Study
This study looked at 74 people on dialysis to see if bone markers predict problems with their dialysis tubes. It found a link between certain blood levels and the need for more tube repairs. This shows a connection, but it does not prove that the blood levels cause the tube problems.
Effectiveness of Erythropoiesis-Stimulating Agent Therapy with Oral and Intravenous Iron Supplementation in Achieving Hemoglobin Targets in Stage 5 Chronic Kidney Disease Patients
This study looked at how to treat anemia in people with stage 5 kidney disease. It compared taking iron by mouth versus getting it through a vein. The study found that both methods can help raise blood counts. This is an observational study, so it shows a link, not proof of cause.
Safety and Feasibility of Carbon Dioxide Angiography for Stenting of Atherosclerotic Renal Artery Stenosis: A Retrospective Comparative Study
This study compared two ways to take pictures of kidney arteries during a procedure. One method used carbon dioxide gas, and the other used standard dye. The study found that the gas method was safe for 99 patients. This is a retrospective study, so it looks at past records and shows a link, not proof of cause.
The FGF23–Undercarboxylated Osteocalcin Axis in Predialysis Chronic Kidney Disease: Linking Mineral Homeostasis and Bone Turnover
This study looked at 80 adults, including 68 with kidney disease. It checked how two bone-related proteins interact in the blood. The study found a link between these proteins and kidney function. This is an observational study, so it shows a connection but not proof that one causes the other.